ELI LILLY & Co — Director's Dealing 2015

Jul 29, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-07-28

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-28	Common Stock	S	25000	$84.96	Disposed	62728	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1619	Indirect
Common Stock	1608	Indirect
Common Stock	8984	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.